Mary Honkanen, MD
Internal Medicine · Mobile, ALNPI 1316986052
Payments from drug & device makers
Across 1,051 payments — averaging $287.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$120K
- Amarin Pharma, Inc.$87K
- Amgen$62K
- Esperion Therapeutics, Inc.$15K
- Regeneron Healthcare Solutions, Inc.$5K
- Kowa Pharmaceuticals America, Inc.$4K
- plus $8K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 286 | $120,279 |
| Amarin Pharma, Inc. | 258 | $87,276 |
| Amgen | 117 | $62,402 |
| Esperion Therapeutics, Inc. | 30 | $15,369 |
| Regeneron Healthcare Solutions, Inc. | 33 | $4,785 |
| Kowa Pharmaceuticals America, Inc. | 43 | $4,238 |
| Sanofi-aventis U.S. LLC | 21 | $3,172 |
| AstraZeneca | 47 | $1,311 |
| Lilly USA, LLC | 47 | $696 |
| Novartis | 52 | $621 |
| Bayer | 18 | $457 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 23 | $396 |
| Boehringer Ingelheim | 24 | $370 |
| Johnson & Johnson | 11 | $211 |
| Janssen Scientific Affairs, LLC | 1 | $124 |
| Xeris Pharmaceuticals, Inc. | 5 | $91 |
| Corcept Therapeutics | 5 | $89 |
| Dexcom, Inc. | 6 | $83 |
| Amryt Pharma Holdings Ltd | 4 | $74 |
| BD | 3 | $73 |
| Aegerion Pharmaceuticals, Inc. | 4 | $69 |
| Merck | 3 | $39 |
| Abbott | 1 | $25 |
| Tandem Diabetes Care, Inc. | 2 | $24 |
| Chiesi USA, Inc. | 1 | $22 |
| BETA Bionics, Inc. | 1 | $22 |
| Mannkind Corporation | 1 | $19 |
| Insulet Corporation | 1 | $17 |
| Medtronic | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Lifescan, Inc. | 1 | $12 |
How this compares
$302,395 in reported general payments places this provider in the 95th percentile of 1,533 internal medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Mobile
- Harry StuddardMobile$12.9M
- Thomas McKelveyMobile$365K
- Bobby WrightsMobile$89K
- Rahel AzizMobile$67K
- Jamie CaudillMobile$52K
- Thomas GarthMobile$48K
- Lin LiMobile$45K
- Edward CarlosMobile$26K
- Donald SandersMobile$23K
- Amy StrassburgMobile$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.